274 related articles for article (PubMed ID: 15749258)
1. Pregnancy outcome after exposure to ranitidine and other H2-blockers. A collaborative study of the European Network of Teratology Information Services.
Garbis H; Elefant E; Diav-Citrin O; Mastroiacovo P; Schaefer C; Vial T; Clementi M; Valti E; McElhatton P; Smorlesi C; Rodriguez EP; Robert-Gnansia E; Merlob P; Peiker G; Pexieder T; Schueler L; Ritvanen A; Mathieu-Nolf M
Reprod Toxicol; 2005; 19(4):453-8. PubMed ID: 15749258
[TBL] [Abstract][Full Text] [Related]
2. Post-marketing surveillance system for drugs in pregnancy--15 years experience of ENTIS.
Schaefer C; Hannemann D; Meister R
Reprod Toxicol; 2005; 20(3):331-43. PubMed ID: 15978773
[TBL] [Abstract][Full Text] [Related]
3. Safety of first trimester exposure to H2 blockers.
Lagace E
J Fam Pract; 1996 Oct; 43(4):342-3. PubMed ID: 8874364
[No Abstract] [Full Text] [Related]
4. Outcome of pregnancy after first trimester exposure to H2 receptor antagonists.
Koren G; Zemlickis DM
Am J Perinatol; 1991 Jan; 8(1):37-8. PubMed ID: 1670987
[TBL] [Abstract][Full Text] [Related]
5. Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study.
Schaefer C; Hannemann D; Meister R; Eléfant E; Paulus W; Vial T; Reuvers M; Robert-Gnansia E; Arnon J; De Santis M; Clementi M; Rodriguez-Pinilla E; Dolivo A; Merlob P
Thromb Haemost; 2006 Jun; 95(6):949-57. PubMed ID: 16732373
[TBL] [Abstract][Full Text] [Related]
6. The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational study.
Weber-Schoendorfer C; Hannemann D; Meister R; Eléfant E; Cuppers-Maarschalkerweerd B; Arnon J; Vial T; Rodriguez-Pinilla E; Clementi M; Robert-Gnansia E; De Santis M; Malm H; Dolivo A; Schaefer C
Reprod Toxicol; 2008 Sep; 26(1):24-30. PubMed ID: 18585452
[TBL] [Abstract][Full Text] [Related]
7. Low dose methotrexate in the first trimester of pregnancy: results of a French collaborative study.
Lewden B; Vial T; Elefant E; Nelva A; Carlier P; Descotes J;
J Rheumatol; 2004 Dec; 31(12):2360-5. PubMed ID: 15570635
[TBL] [Abstract][Full Text] [Related]
8. Pregnancy outcome after gestational exposure to the new macrolides: a prospective multi-center observational study.
Bar-Oz B; Diav-Citrin O; Shechtman S; Tellem R; Arnon J; Francetic I; Berkovitch M; Ornoy A
Eur J Obstet Gynecol Reprod Biol; 2008 Nov; 141(1):31-4. PubMed ID: 18760873
[TBL] [Abstract][Full Text] [Related]
9. The safety of H(2)-blockers use during pregnancy.
Matok I; Gorodischer R; Koren G; Sheiner E; Wiznitzer A; Uziel E; Levy A
J Clin Pharmacol; 2010 Jan; 50(1):81-7. PubMed ID: 19789371
[TBL] [Abstract][Full Text] [Related]
10. Adverse effects of prenatal methimazole exposure.
Di Gianantonio E; Schaefer C; Mastroiacovo PP; Cournot MP; Benedicenti F; Reuvers M; Occupati B; Robert E; Bellemin B; Addis A; Arnon J; Clementi M
Teratology; 2001 Nov; 64(5):262-6. PubMed ID: 11745832
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II-receptor-antagonists: further evidence of fetotoxicity but not teratogenicity.
Schaefer C
Birth Defects Res A Clin Mol Teratol; 2003 Aug; 67(8):591-4. PubMed ID: 14632309
[TBL] [Abstract][Full Text] [Related]
12. Isotretinoin exposure and pregnancy outcome: an observational study of the Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy.
Schaefer C; Meister R; Weber-Schoendorfer C
Arch Gynecol Obstet; 2010 Feb; 281(2):221-7. PubMed ID: 19444462
[TBL] [Abstract][Full Text] [Related]
13. Pregnancy outcome following maternal exposure to statins: a multicentre prospective study.
Winterfeld U; Allignol A; Panchaud A; Rothuizen LE; Merlob P; Cuppers-Maarschalkerweerd B; Vial T; Stephens S; Clementi M; De Santis M; Pistelli A; Berlin M; Eleftheriou G; Maňáková E; Buclin T
BJOG; 2013 Mar; 120(4):463-71. PubMed ID: 23194157
[TBL] [Abstract][Full Text] [Related]
14. Pregnancy outcome following first-trimester exposure to zopiclone: a prospective controlled cohort study.
Diav-Citrin O; Okotore B; Lucarelli K; Koren G
Am J Perinatol; 1999; 16(4):157-60. PubMed ID: 10458526
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy outcome of women inadvertently exposed to ribostamycin during early pregnancy: a prospective cohort study.
Lee SW; Han JY; Choi JS; Chung JH; Kim MY; Yang JH; Koong MK; Nava-Ocampo AA; Koren G
Reprod Toxicol; 2009 Apr; 27(2):196-8. PubMed ID: 19162171
[TBL] [Abstract][Full Text] [Related]
16. High vitamin A intake in early pregnancy and major malformations: a multicenter prospective controlled study.
Mastroiacovo P; Mazzone T; Addis A; Elephant E; Carlier P; Vial T; Garbis H; Robert E; Bonati M; Ornoy A; Finardi A; Schaffer C; Caramelli L; Rodríguez-Pinilla E; Clementi M
Teratology; 1999 Jan; 59(1):7-11. PubMed ID: 9988877
[TBL] [Abstract][Full Text] [Related]
17. Fetal outcome after technetium scintigraphy in early pregnancy.
Schaefer C; Meister R; Wentzeck R; Weber-Schoendorfer C
Reprod Toxicol; 2009 Sep; 28(2):161-6. PubMed ID: 19442716
[TBL] [Abstract][Full Text] [Related]
18. Pregnancy outcome after in utero exposure to colchicine.
Diav-Citrin O; Shechtman S; Schwartz V; Avgil-Tsadok M; Finkel-Pekarsky V; Wajnberg R; Arnon J; Berkovitch M; Ornoy A
Am J Obstet Gynecol; 2010 Aug; 203(2):144.e1-6. PubMed ID: 20579964
[TBL] [Abstract][Full Text] [Related]
19. Prenatal exposure to salicylates and gastroschisis: a case-control study.
Martínez-Frías ML; Rodríguez-Pinilla E; Prieto L
Teratology; 1997 Oct; 56(4):241-3. PubMed ID: 9408974
[TBL] [Abstract][Full Text] [Related]
20. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies.
Park-Wyllie L; Mazzotta P; Pastuszak A; Moretti ME; Beique L; Hunnisett L; Friesen MH; Jacobson S; Kasapinovic S; Chang D; Diav-Citrin O; Chitayat D; Nulman I; Einarson TR; Koren G
Teratology; 2000 Dec; 62(6):385-92. PubMed ID: 11091360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
